SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001723128-23-000023
Filing Date
2023-05-12
Accepted
2023-05-12 16:29:52
Documents
12
Period of Report
2023-05-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K amrx-20230509.htm   iXBRL 8-K 101971
  Complete submission text file 0001723128-23-000023.txt   241261

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20230509.xsd EX-101.SCH 1993
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20230509_lab.xml EX-101.LAB 24137
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20230509_pre.xml EX-101.PRE 12597
6 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20230509_htm.xml XML 10858
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 23916266
SIC: 2834 Pharmaceutical Preparations